369 related articles for article (PubMed ID: 9833990)
1. Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms.
Savolainen J; Järvinen K; Taipale H; Jarho P; Loftsson T; Järvinen T
Pharm Res; 1998 Nov; 15(11):1696-701. PubMed ID: 9833990
[TBL] [Abstract][Full Text] [Related]
2. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
Rao VM; Haslam JL; Stella VJ
J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
[TBL] [Abstract][Full Text] [Related]
3. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
4. Nanoaggregation of inclusion complexes of glibenclamide with cyclodextrins.
Lucio D; Irache JM; Font M; Martínez-Ohárriz MC
Int J Pharm; 2017 Mar; 519(1-2):263-271. PubMed ID: 28111282
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers.
Nie S; Zhang S; Pan W; Liu Y
Drug Dev Ind Pharm; 2011 May; 37(5):606-12. PubMed ID: 21469949
[TBL] [Abstract][Full Text] [Related]
6. Daidzein/cyclodextrin/hydrophilic polymer ternary systems.
Borghetti GS; Pinto AP; Lula IS; Sinisterra RD; Teixeira HF; Bassani VL
Drug Dev Ind Pharm; 2011 Aug; 37(8):886-93. PubMed ID: 21247375
[TBL] [Abstract][Full Text] [Related]
7. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.
Aggarwal S; Singh PN; Mishra B
Pharmazie; 2002 Mar; 57(3):191-3. PubMed ID: 11933849
[TBL] [Abstract][Full Text] [Related]
8. New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD.
Ma DQ; Rajewski RA; Stella VJ
Int J Pharm; 1999 Nov; 189(2):227-34. PubMed ID: 10536251
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.
Okimoto K; Miyake M; Ohnishi N; Rajewski RA; Stella VJ; Irie T; Uekama K
Pharm Res; 1998 Oct; 15(10):1562-8. PubMed ID: 9794499
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.
Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Irie T; Uekama K; Rajewski RA; Stella VJ
Pharm Res; 1999 Apr; 16(4):549-54. PubMed ID: 10227711
[TBL] [Abstract][Full Text] [Related]
11. beta-cyclodextrin derivatives, SBE4-beta-CD and HP-beta-CD, increase the oral bioavailability of cinnarizine in beagle dogs.
Järvinen T; Järvinen K; Schwarting N; Stella VJ
J Pharm Sci; 1995 Mar; 84(3):295-9. PubMed ID: 7616366
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
Taupitz T; Dressman JB; Buchanan CM; Klein S
Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
[TBL] [Abstract][Full Text] [Related]
13. Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes.
Jain AC; Aungst BJ; Adeyeye MC
J Pharm Sci; 2002 Jul; 91(7):1659-68. PubMed ID: 12115827
[TBL] [Abstract][Full Text] [Related]
14. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD.
Zia V; Rajewski RA; Stella VJ
Pharm Res; 2001 May; 18(5):667-73. PubMed ID: 11465424
[TBL] [Abstract][Full Text] [Related]
16. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
[TBL] [Abstract][Full Text] [Related]
17. Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes.
Elbary AA; Kassem MA; Abou Samra MM; Khalil RM
Drug Discov Ther; 2008 Apr; 2(2):94-107. PubMed ID: 22504505
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
Jarho P; Vander Velde D; Stella VJ
J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
[TBL] [Abstract][Full Text] [Related]
19. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
Kopecký F; Kopecká B
Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
[TBL] [Abstract][Full Text] [Related]
20. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.
Okimoto K; Rajewski RA; Stella VJ
J Control Release; 1999 Mar; 58(1):29-38. PubMed ID: 10021487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
